Immunofluorescence (IF) and in situ proximity ligation assay (isPLA) are techniques that are used for in situ protein expression and colocalisation analysis, respectively.
| BACKGROUND
Immunofluorescence (IF) and in situ proximity ligation assay (isPLA) are methods used for studies of protein expression and colocalisation, respectively. IF staining can reveal the location and relative expression level of a protein. The isPLA detects colocalisation of 2 target proteins at a maximal distance of 30 nm in situ with high specificity. [1] isPLA signals, each representing one colocalisation, are seen as fluorescent spots under the microscope. [1] Both IF and isPLA have already been applied in subjective and semi-quantitative analysis of protein expression and colocalisation in skin sections. [2, 3] However, an efficient quantitative image analysis method for IF and isPLA is lacking. A previous report described advanced automatic segmentation of the epidermal part of the images using the commercial scripting tool Matlab. [4] Another study used the open-source software ImageJ to quantify colorimetric staining of melanin in skin without segmentation of the epidermis. [5] CellProfiler is also a free and open-source software and does not require any programming skills, which makes it easy to handle. [6] CellProfiler uses socalled pipelines, which are composed of individual image-processing modules, to analyse many images automatically. Therefore, we developed new CellProfiler pipelines for analysis of IF and isPLA staining of skin sections in an objective and quantitative way. 
| QUESTION ADDRESSED

| RESULTS AND DISCUSSION
The 3 pipelines were used to measure IF staining intensities ( Figure 1) and isPLA signals ( Figure 2 ) in skin sections. Figure 1 shows an example of IF staining of transglutaminase-1 (TGm-1) ( Figure 1A ) and short-chain dehydrogenase/reductase family 9C member 7 (SDR9C7) ( Figure 1D ), 2 genes causing autosomal recessive congenital ichthyosis. [7] ROIs were manually outlined with Pipeline II ( Figure 1B ,E) and subsequently automatically divided into up to 20 layers by Pipeline F I G U R E 1 Quantification of immunofluorescence (IF) staining in normal skin using customised CellProfiler pipelines. Microphotographs of IF of TGm-1 (green) (A) and SDR9C7 (red) (D) with nuclear counterstaining (blue) were obtained and exported as lossless .tif images. Regions-of-interest (ROIs) were manually outlined via Pipeline II (B and E). The ROIs were automatically divided into layers, each corresponding to 8 μm in thickness (almost one layer of viable keratinocytes), by Pipeline III. The median fluorescence intensity within each layer was extracted (C and F). The intensities were plotted against the skin depth from stratum corneum (sc, grey zone) (−12 μm) to reticular dermis (100 μm) (G); 0 μm represents the top of the uppermost nucleated layer of stratum granulosum (sg), positive values denote depth below sg and negative values above sg. The brightness and contrast were adjusted for viewing purposes. AU, arbitrary unit. Scale bar = 16.1 μm For isPLA, the z-stack collection was compressed to a single image 
| CONCLUSION
In conclusion, the developed quantitative method for IF and isPLA measurements can be widely used for future studies of protein expression and colocalisation in skin sections.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article.
DATA S1 Materials and methods
FIGURE S1
Schematic illustration of the operating procedure using 
Abstract
The purpose of this study was to establish a small-animal model for molecular imaging and to acquire basic data on assessing the efficacy of candidate melanoma drugs using small-animal PET imaging analysis with [ 
| BACKGROUND
Recent research has developed and used small-animal imaging methods that have high sensitivity and resolution and that can measure living organisms at the level of cells or molecules. [1] As these non-invasive imaging technologies do not require sacrifice of the experimental animals and can verify benefits to organs, they are proposed as a main research methodology for drug development.
Reporter genes for non-invasive molecular images include bioluminescent, [2] fluorescent [3] and PET reporter gene (PRG). Nuclear medical molecular imaging technologies using PRG/PET reporter probe (PRP) systems have been actively studied. Along with reporter genes, introducing fusion genes associated with the genes of interest in such areas as cancer cell death or angiogenesis around tumors can be used to evaluate the expressions of associated genes. Studies combining optical, fluorescence and PRGs to generate complex molecular images have been carried out. [4, 5] 
